Personalis, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Personalis, Inc. (PSNL) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $4.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-04
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $4.72M, a 226.17% increase year-over-year.
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$426.00K.
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $1.78M, a 134.47% increase year-over-year.
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.82M, a 22.70% decline year-over-year.
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $2.31M.
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$2.40M, a 423.58% decline from fiscal 2023.
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $742.00K.
- Personalis, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$1.48M, a 143.95% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.30M 10-Q · filed 2026-08-04 | $6.08M derived: sum of 3 quarters · filed 2026-08-04 | $7.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$426.00K 10-Q · filed 2026-05-07 | $1.36M derived: sum of 2 quarters · filed 2026-05-07 | $3.17M derived: sum of 3 quarters · filed 2026-05-07 | $4.62M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.60M derived: sum of 2 quarters · filed 2026-02-26 | $5.05M derived: sum of 3 quarters · filed 2026-08-04 | $2.31M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.27M derived: sum of 2 quarters · filed 2026-08-04 | $524.00K 10-Q · filed 2025-11-04 | $1.28M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.29M 10-Q · filed 2026-08-04 | -$534.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.82M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$2.74M 10-Q · filed 2026-05-07 | -$1.98M derived: sum of 2 quarters · filed 2026-05-07 | $370.00K derived: sum of 3 quarters · filed 2026-05-07 | $2.69M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $760.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.11M derived: sum of 2 quarters · filed 2026-02-26 | $5.43M derived: sum of 3 quarters · filed 2026-02-26 | -$2.40M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.67M derived: sum of 2 quarters · filed 2025-11-04 | -$3.16M 10-Q · filed 2025-11-04 | -$3.44M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$5.51M 10-Q · filed 2025-08-05 | -$5.79M derived: sum of 3 quarters · filed 2025-08-05 | -$2.41M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$7.84M 10-Q · filed 2025-05-06 | -$8.11M derived: sum of 2 quarters · filed 2025-05-06 | -$4.74M derived: sum of 3 quarters · filed 2025-05-06 | -$7.52M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | -$276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.10M derived: sum of 2 quarters · filed 2025-02-27 | $316.00K derived: sum of 3 quarters · filed 2025-02-27 | $742.00K 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $592.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.02M 10-Q · filed 2024-11-06 | $1.17M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | -$2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$2.36M 10-Q · filed 2024-08-07 | -$2.20M derived: sum of 3 quarters · filed 2024-08-07 | -$3.67M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $426.00K 10-Q · filed 2024-05-08 | $579.00K derived: sum of 2 quarters · filed 2024-05-08 | -$888.00K derived: sum of 3 quarters · filed 2024-05-08 | -$4.45M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$1.31M derived: sum of 2 quarters · filed 2024-02-28 | -$4.88M derived: sum of 3 quarters · filed 2024-02-28 | -$1.48M 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$5.03M derived: sum of 2 quarters · filed 2023-11-07 | -$1.63M 10-Q · filed 2023-11-07 | -$106.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | -$3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$165.00K 10-Q · filed 2023-08-08 | $1.36M derived: sum of 3 quarters · filed 2024-02-28 | $4.59M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $3.40M 10-Q · filed 2023-05-03 | $4.92M derived: sum of 2 quarters · filed 2024-02-28 | $8.15M derived: sum of 3 quarters · filed 2024-02-28 | $4.29M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.75M derived: sum of 2 quarters · filed 2024-02-28 | $894.00K derived: sum of 3 quarters · filed 2024-02-28 | $3.37M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$632.00K derived: sum of 2 quarters · filed 2022-11-02 | $1.84M 10-Q · filed 2022-11-02 | $4.19M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$1.39M 10-Q · filed 2022-08-03 | $965.00K derived: sum of 3 quarters · filed 2023-02-23 | $2.94M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $2.47M 10-Q · filed 2022-05-04 | $4.83M derived: sum of 2 quarters · filed 2023-02-23 | $6.80M derived: sum of 3 quarters · filed 2023-02-23 | $5.02M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.33M derived: sum of 2 quarters · filed 2023-02-23 | $2.55M derived: sum of 3 quarters · filed 2023-02-23 | $3.53M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $191.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.17M 10-Q · filed 2021-11-04 | $2.16M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$797.00K 10-Q · filed 2021-08-04 | $186.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.80M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $983.00K 10-Q · filed 2021-05-05 | $729.00K 10-Q · filed 2020-05-07 | $1.97M derived: sum of 2 quarters · filed 2022-02-24 | $3.58M derived: sum of 3 quarters · filed 2022-02-24 | $1.37M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.60M derived: sum of 2 quarters · filed 2022-02-24 | $384.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.97M 10-K · filed 2022-02-24 | $2.00M 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$599.00K derived: sum of 2 quarters · filed 2020-11-05 | $988.00K 10-Q · filed 2020-11-05 | $1.08M 10-Q · filed 2019-11-13 | $1.44M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$624.00K 10-Q · filed 2020-08-06 | -$567.00K 10-Q · filed 2019-08-13 | -$169.00K derived: sum of 3 quarters · filed 2021-02-25 | $422.00K derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $1.59M 10-Q · filed 2020-05-07 | $2.04M derived: sum of 2 quarters · filed 2021-02-25 | $2.63M derived: sum of 3 quarters · filed 2021-02-25 | |||||
| 2018-12-31 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.05M derived: sum of 2 quarters · filed 2021-02-25 | $997.00K 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | $591.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $542.00K 10-Q · filed 2019-11-13 | ||||||
| 2018-06-30 | -$49.00K 10-Q · filed 2019-08-13 | |||||||
| 2017-12-31 | $684.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |